Development and validation of an analytical method to quantify baphicacanthin A by LC-MS/MS and its application to pharmacokinetic studies in mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In this study, we developed and validated a sensitive analytical method to quantify baphicacanthin A in mouse plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The standard calibration curves for baphicacanthin A ranged from 0.5 to 200 ng/mL and were linear, with an r2 of 0.985. The inter- and intra-day accuracy and precision and the stability fell within the acceptance criteria. Besides, we investigated the pharmacokinetics of baphicacanthin A following its intravenous (5 mg/kg) and oral administration (30 mg/kg). Intravenously injected baphicacanthin A showed biphasic elimination kinetics with high clearance and volume of distribution values. Furthermore, baphicacanthin A showed a rapid absorption but low aqueous solubility (182.51±0.20 mg/mL), resulting in low plasma concentrations and low oral bioavailability (2.49%). Thus, we successfully documented the pharmacokinetic properties of baphicacanthin A using this newly developed sensitive LC-MS/MS quantification method, which could be used in future lead optimization and biopharmaceutic studies.
Abstract
In this study, we developed and validated a sensitive analytical method to quantify baphicacanthin A in mouse plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The standard calibration curves for baphicacanthin A ranged from 0.5 to 200 ng/mL and were linear, with an r2 of 0.985. The inter- and intra-day accuracy and precision and the stability fell within the acceptance criteria. Besides, we investigated the pharmacokinetics of baphicacanthin A following its intravenous (5 mg/kg) and oral administration (30 mg/kg). Intravenously injected baphicacanthin A showed biphasic elimination kinetics with high clearance and volume of distribution values. Furthermore, baphicacanthin A showed a rapid absorption but low aqueous solubility (182.51±0.20 mg/mL), resulting in low plasma concentrations and low oral bioavailability (2.49%). Thus, we successfully documented the pharmacokinetic properties of baphicacanthin A using this newly developed sensitive LC-MS/MS quantification method, which could be used in future lead optimization and biopharmaceutic studies.
참고문헌 (22)
- M. Le Roes-Hill, , Trends in Biotechnology, 27(4), pp.248~258 (2009)
- C. Eggert, , FEBS Letters, 376(3), pp.202~206 (1995)
- A. Bolognese, , Journal of Medicinal Chemistry, 45(24), pp.5205~5216 (2002)
- N. Lohani, , International Journal of Biological Macromolecules, 87, pp.433~442 (2016)
- S. Katsamakas, , Current Medicinal Chemistry, 23(26), pp.2972~2999 (2016)
- 안성완, "The First Synthesis of Baphicacanthin A, a Natural Phenoxazinone Alkaloid Derived from Baphicacanthus cusia", Bulletin of the Korean Chemical Society, 40(7), pp.740~742 (2019), 대한화학회[DOI]
- Q. -T. Feng, , Chemical and Pharmaceutical Bulletin, 64(10), pp.1505~1508 (2016)
- T. Tanaka, , Chemical and Pharmaceutical Bulletin, 52(10), pp.1242~1245 (2004)
- B. Zhou, , Journal of Ethnopharmacology, 199, pp.60~67 (2017)
- Y. Cuan, , Natural Product Research (2021)[DOI]
- K. B. Adhikari, , Journal of Agricultural and Food Chemistry, 60(46), pp.11518~11524 (2012)
- K. B. Adhikari, , Journal of Agricultural and Food Chemistry, 60(10), pp.2497~2506 (2012)
- S. K. Steffensen, , Journal of Agricultural and Food Chemistry, 64(43), pp.8235~8245 (2016)
- M. K. Choi, , Pharmaceutics, 12(3), pp.268~ (2020)
- Ji‑Hyeon Jeon, "Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract signifi cantly differ between species of experimental animals", Archives of Pharmacal Research, 43(12), pp.1335~1346 (2020), 대한약학회[DOI]
- J. H. Jeon, , Pharmaceutics, 13(9), pp.1496~ (2021)
- Ji-Hyeon Jeon, "Correlation between the Content and Pharmacokinetics of Ginsenosides from Four Different Preparation of Panax Ginseng C.A. Meyer in Rats", Mass Spectrometry Letters, 12(1), pp.16~20 (2021), 사단법인 한국질량분석학회
- Minyeong Pang, "Development of a Sensitive Analytical Method of Polynemoraline C Using LC- MS", MS and Its Application to a Pharmacokinetic Study in Mice, 2021, pp.12(4), 200~205[DOI]
- S. Chandran, , Die Pharmazie, 62(1), pp.4~14 (2007)
- L. Tanner, , Antimicrobial Agents and Chemotherapy, 63(11), pp.e01010~19 (2019)
- K. B. Adhikari, , Molecular Nutrition & Food Research, 57(10), pp.1847~1858 (2013)
- B. M. Jensen, , European Journal of Nutrition, 56(1), pp.387~397 (2017)